Related Experiment Video
Updated: May 12, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Primary Membranous Nephropathy: A
Paula Dibo1, Henrique Alexsander Ferreira Neves2, Raghunandan Konda3
1Division of General Internal Medicine, Department of Medicine, Emory University, AtlantaGA, USA.
Introduction:
Primary membranous nephropathy (PMN) is a leading cause of nephrotic syndrome in adults and is associated with an increased risk of thromboembolic events. The anti-serum phospholipase A2 receptor antibody (anti-PLA2R Ab) is highly specific for PMN, correlates with immunological disease activity, and evidence suggests that it may contribute to a prothrombotic state. This systematic review and meta-analysis aimed to further explore the potential association between serum anti-PLA2R Ab and thromboembolic events in patients with PMN and investigate whether they may serve as a possible biomarker for thrombogenesis.
Methods:
PubMed, Embase, and Cochrane databases were systematically searched for studies that investigated the presence of anti-PLA2R Ab as a potential risk factor for thrombogenesis in patients with PMN. Odds ratios (ORs) and mean differences with 95% confidence intervals (CIs) were pooled across studies. Heterogeneity was evaluated using I2 statistics.
Results:
We included seven studies involving 1,162 patients; mean age was 53 years. Patients with anti-PLA2R Ab had significantly higher odds of thromboembolism compared to those without anti-PLA2R Ab (OR 1.52; 95% CI 1.10, 2.09; p = 0.01). Patients diagnosed with thromboembolism exhibited significantly lower serum albumin levels compared to those without thromboembolism (p = 0.003), but there were no statistical differences in proteinuria (p = 0.18) or age (p = 0.90) between patients with and without thromboembolism. Proteinuria (p = 0.59), serum creatinine (p = 0.77), or estimated glomerular filtration rate (p = 0.59) did not differ between anti-PLA2R Ab-positive and negative patients. However, total cholesterol levels were higher in patients with positive anti-PLA2R Ab (p < 0.0001).
Conclusion:
There was a significant association between the presence of anti-PLA2R Ab and the risk of thromboembolism in patients with PMN, supporting their potential use as a biomarker for thrombogenesis in this population.
Insights
The anti-serum phospholipase A2 receptor antibody (anti-PLA2R Ab) is linked to a higher risk of thromboembolism in primary membranous nephropathy (PMN) patients. This finding supports anti-PLA2R Ab as a potential biomarker for thrombogenesis in PMN.
Area of Science:
- Nephrology
- Immunology
- Thrombosis
Background:
- Primary membranous nephropathy (PMN) is a major cause of nephrotic syndrome in adults.
- PMN is associated with an elevated risk of thromboembolic events.
- The anti-serum phospholipase A2 receptor antibody (anti-PLA2R Ab) is specific to PMN and may promote a prothrombotic state.
Purpose of the Study:
- To systematically review and meta-analyze the association between serum anti-PLA2R Ab and thromboembolic events in PMN patients.
- To investigate the potential of anti-PLA2R Ab as a biomarker for thrombogenesis.
Main Methods:
- Systematic search of PubMed, Embase, and Cochrane databases.
- Inclusion of seven studies with 1,162 PMN patients.
- Pooled analysis of odds ratios (ORs) and mean differences with 95% confidence intervals (CIs); heterogeneity assessed using I² statistics.
Main Results:
- Patients with anti-PLA2R Ab had significantly higher odds of thromboembolism (OR 1.52; 95% CI 1.10, 2.09; p = 0.01).
- Thromboembolism was associated with lower serum albumin (p = 0.003) but not proteinuria or age.
- Higher total cholesterol levels were observed in anti-PLA2R Ab-positive patients (p < 0.0001).
Conclusions:
- A significant association exists between anti-PLA2R Ab presence and thromboembolism risk in PMN.
- Anti-PLA2R Ab may serve as a valuable biomarker for predicting thrombogenesis in PMN patients.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Peripheral Artery Disease I: Introduction
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
